In France

Important (and less important) announcements

  • Vivendi obtains Spain’s approval to increase its stake in Prisa.
  • Alstom has appointed Bernard Delpit as the new Group Executive Vice President and Chief Financial Officer effective June 30.
  • S&P raised Verallia’s long-term issuer credit rating from “BB+” to “BBB-“, with a positive outlook. This increase marks the passage of the debt from the speculative category to the investment category.
  • Vallourec announces the return to full operation of the Pau Branco mine.
  • ABB announces its collaboration with Lhyfe and Skyborn on the SoutH2Port project.
  • John Textor becomes CEO of Olympique Lyonnais Groupe. Jean-Michel Aulas honorary president.
  • They have published / They must publish : Buy-Rent…

In the world

Company results (comments are given on the spot and do not prejudge the evolution of securities)

  • Almirall: Core profit reached €51.8m in Q1, slightly above expectations.
  • Berkshire Hathaway: quarterly operating profit exceeds $8 billion.
  • PostNL: operating profit finally slightly positive in Q1, at €7m.

Important (and less important) announcements

  • ISS recommends shareholders vote once morest Shell’s climate activists’ resolution.
  • HSBC shareholders block Ping An’s Asian split proposal and dividend policy change.
  • Assa Abloy is going to sell several brands to secure the American antitrust green light in connection with the takeover of Spectrum Brands for $4.3 billion.
  • Coty is considering a double listing in Paris (Adrien Chavanne just made a presentation of Coty last week here. Does he have inside information?.
  • Buffett says Apple is the best company in Berkshire’s portfolio.
  • US justice is investigating possible violations of Russian sanctions by Binance.
  • Pinduoduo denies the transfer of its head office to Ireland.
  • US justice is investigating insider trading by First Republic executives.
  • Pacwest soars 82% on Wall Street.
  • The main publications of the day: PayPal, Westpac, McKesson, KKR, Hoya, Marubeni, BioNtech… The whole agenda here.

Lectures